Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study
Author:
Affiliation:
1. University of Southern Denmark; Odense C Denmark
2. RTI Health Solutions; Barcelona Spain
3. Astellas Pharma B.V.; Leiden The Netherlands
4. Astellas Pharma Global Development, Inc.; Northbrook IL USA
5. RTI Health Solutions; Waltham MA USA
Funder
Astellas Pharma Global Development
Publisher
Wiley
Subject
Pharmacology,Toxicology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12965/fullpdf
Reference19 articles.
1. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society;Abrams;Urology,2003
2. The prevalence and bothersomeness of lower urinary tract symptoms in women 40-60 years of age;Møller;Acta Obstet Gynecol Scand,2000
3. Characteristics of middle-aged and elderly women with urinary incontinence;Rohr;Scand J Prim Health Care,2005
4. Global prevalence and economic burden of urgency urinary incontinence: a systematic review;Milsom;Eur Urol,2014
5. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses;eBioMedicine;2023-12
2. The application of lag times in cancer pharmacoepidemiology: a narrative review;Annals of Epidemiology;2023-08
3. Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study;Lung Cancer;2023-05
4. A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder;Current Medical Research and Opinion;2021-03-08
5. Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer;Clinical Epidemiology;2019-01
Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3